These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36009109)

  • 21. [Facial diplegia with atypical paresthesia. A variant of Guillain-Barré syndrome].
    Dal Verme A; Acosta P; Margan M; Pagnini C; Dellepiane E; Peralta C
    Medicina (B Aires); 2015; 75(3):178-80. PubMed ID: 26117611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
    Bouattour N; Hdiji O; Sakka S; Fakhfakh E; Moalla K; Daoud S; Farhat N; Damak M; Mhiri C
    Neurol Sci; 2022 Feb; 43(2):755-761. PubMed ID: 34796417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
    Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
    Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias.
    Wakerley BR; Yuki N
    Muscle Nerve; 2015 Dec; 52(6):927-32. PubMed ID: 26315943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-Associated Autoimmune Disease: A Rare First Case Report of Acute Motor Axonal Neuropathy Variant of Guillain-Barre Syndrome in a Woman Patient in New York City.
    Qureshi Z; Kandhi S; Prasai N; Altaf F; Dhallu M
    Cureus; 2022 Feb; 14(2):e22290. PubMed ID: 35350485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bifacial weakness with paresthesias: Serial nerve conduction studies indicate diffuse demyelinating neuropathy.
    Morgan C; Fuller G; Wakerley BR
    Muscle Nerve; 2016 May; 53(5):818-22. PubMed ID: 26790030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cranial Nerve Involvement and Dysautonomia in Post-COVID-19 Guillain-Barré Syndrome.
    Kakumoto T; Kobayashi S; Yuuki H; Kainaga M; Shirota Y; Hamada M; Hashimoto Maeda M; Kubota A; Kawai M; Saito M; Ishiura H; Toda T
    Intern Med; 2021 Nov; 60(21):3477-3480. PubMed ID: 34433712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facial Diplegia with Paresthesia: An Uncommon Variant of Guillain-Barre Syndrome.
    Kumar P; Charaniya R; Bahl A; Ghosh A; Dixit J
    J Clin Diagn Res; 2016 Jul; 10(7):OD01-2. PubMed ID: 27630886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.
    Bonifacio GB; Patel D; Cook S; Purcaru E; Couzins M; Domjan J; Ryan S; Alareed A; Tuohy O; Slaght S; Furby J; Allen D; Katifi HA; Kinton L
    J Neurol Neurosurg Psychiatry; 2022 Mar; 93(3):341-342. PubMed ID: 34261746
    [No Abstract]   [Full Text] [Related]  

  • 30. A Case of Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome With Bilateral Glossopharyngeal Paralysis.
    He N; Kartiko MC; Selim M
    Cureus; 2021 Apr; 13(4):e14551. PubMed ID: 34017665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-Vaccination Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome.
    Taiwo FT; Ezuduemoih DE; Adebayo PB
    Cureus; 2020 Aug; 12(8):e9804. PubMed ID: 32953316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A unique association of bifacial weakness, paresthesia and vestibulocochlear neuritis as post-COVID-19 manifestation in pregnant women: a case report.
    Aasfara J; Hajjij A; Bensouda H; Ouhabi H; Benariba F
    Pan Afr Med J; 2021; 38():30. PubMed ID: 33777298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review.
    Aladawi M; Elfil M; Abu-Esheh B; Abu Jazar D; Armouti A; Bayoumi A; Piccione E
    Can J Neurol Sci; 2022 Jan; 49(1):38-48. PubMed ID: 33949300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
    Sancho-Saldaña A; Lambea-Gil Á; Liesa JLC; Caballo MRB; Garay MH; Celada DR; Serrano-Ponz M
    Clin Med (Lond); 2020 Jul; 20(4):e93-e94. PubMed ID: 32518103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome in a Patient of COVID-19 Infection.
    Randhawa J; Randhawa HS; Toor P
    Cureus; 2021 Sep; 13(9):e17945. PubMed ID: 34548992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromuscular complications after COVID-19 vaccination: a series of eight patients.
    Leemans W; Antonis S; De Vooght W; Lemmens R; Van Damme P
    Acta Neurol Belg; 2022 Jun; 122(3):753-761. PubMed ID: 35499704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome.
    Moscona-Nissan A; López-Hernández JC; Seidman-Sorsby A; Cruz-Zermeño M; Navalón-Calzada A
    Cureus; 2021 Oct; 13(10):e18788. PubMed ID: 34804654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-​Barré Syndrome Associated with COVID-19 Vaccination.
    Shao SC; Wang CH; Chang KC; Hung MJ; Chen HY; Liao SC
    Emerg Infect Dis; 2021 Dec; 27(12):3175-3178. PubMed ID: 34648420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.